Retinopathy of prematurity: Recent advances in our understanding

British Journal of Ophthalmology

Volumn 86, Issue 6, 2002, Pages 696-700

  Wheatley, C M ^a   Dickinson, J L ^a   Mackey, D A ^b   Craig, J E ^b   Sale, Michèle M ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLINDNESS; DEVELOPING COUNTRY; GENETICS; HUMAN; INFANT; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; RETINOPATHY; REVIEW; RISK FACTOR; SCREENING TEST; SURVIVAL RATE; VISUAL IMPAIRMENT;

DEVELOPING COUNTRIES; HUMANS; INCIDENCE; INFANT, NEWBORN; RETINOPATHY OF PREMATURITY; RISK FACTORS;

EID: 0036283674     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.6.696     Document Type: Review

References (97)

1. Early rehabilitation in retinopathy of prematurity children (0-4 years). Progress in retinopathy of prematurity
2. Childhood blindness and visual loss: An assessment at two institutions including a "new" cause
3. Eight-year outcome in infants with birth weight of 500 to 999 grams: Continuing regional study of 1979 and 1980 births
4. Extremely low birth weight children and their peers: A comparison of preschool performance
5. Implications of the severity of retinopathy of prematurity on childhood development
6. An international classification of retinopathy of prematurity. II. The classification of retinal detachment
7. A global initiative for the elimination of avoidable blindness
8. Childhood blindness in the context of Vision 2020 - The right to sight
9. Childhood blindness
10. Retinopathy of prematurity in middle-income countries
11. Children with blindness due to retinopathy of prematurity: A population-based study. Perinatal data, neurological and ophthalmological outcome
12. Causes of blindness in children attending four schools for the blind in Thailand and the Philippines. A comparison between urban and rural blind school populations
13. Severe retinopathy of prematurity and its association with different rates of survival in infants of less than 1251 g birth weight
14. Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each crystalline lens
15. Intensive oxygen therapy as a possible cause of retrolental fibroplasia: A clinical approach
16. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations
17. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia
18. Blindness in infants and young children
19. Recent increase in mortality from hyaline membrane disease
20. Retinopathy of prematurity: An estimate of vision loss in the United States-1979
21. Retinopathy of prematurity: A new epidemic?
22. Retinopathy of prematurity in infants of 24-30 weeks' gestational age
23. Increased survival of low birth weight infants: Impact on the incidence of retinopathy of prematurity
24. Retinopathy of prematurity in infants less than 29 weeks' gestation at birth
25. Retinopathy of prematurity in a Danish county. Trends over the 12-year period 1982-93
26. Retinopathy of prematurity in infants <29 weeks' gestation at birth in New South Wales from 1986-92
27. The decreasing incidence and severity of retinopathy of prematurity
28. Current incidence of retinopathy of prematurity, 1989-1997
29. Reduced incidence of retinopathy of prematurity
30. Retinopathy of prematurity in infants <32 weeks' gestation at birth in New South Wales in 1993 and 1994
31. Incidence of retinopathy of prematurity in Singapore
32. Retinopathy of prematurity: Review of a seven-year period in a Danish neonatal intensive care unit
33. Risk factors in retinopathy of prematurity. A multivariate statistical analysis
34. What have we learned about retinopathy of prematurity during the past ten years? Progress in retinopathy of prematurity
35. Risk factors in progression beyond stage 2 retinopathy of prematurity
36. Threshold retinopathy of prematurity in neonates less than 25 weeks' estimated gestational age
37. The premature retina: A model for the in vivo study of molecular genetics?
38. Retrolental fibroplasia. II. Pathologic correlation
39. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity
40. The effect of oxygen on vasaformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis
41. Vaso-obliteration in the canine model of oxygen-induced retinopathy
42. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes
43. Transcutaneous oxygen levels in retinopathy of prematurity
44. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat
45. Retinopathy of prematurity: Origins in the architecture of the retina
46. Autoxidative damage to the retina: Potential role in retinopathy of prematurity
47. Lipid peroxidation and antioxidants in erythrocyte membranes of full-term and preterm newborns
48. Retrolental fibroplasia: Further clinical evidence and ultrastructural support for efficacy of vitamin E in the preterm infant
49. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
50. Detection of vascular endothelial growth factor (VEGF) protein in vascular and non-vascular cells of the normal and oxygen-injured rat retina
51. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina
52. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: A new model of intraretinal and subretinal neovascularization
53. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate
54. Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells
55. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity
56. Vascularization of the human fetal retina: Roles of vasculagenesis and angiogenesis
57. Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity
58. Prognostic factors in the natural course of retinopathy of prematurity
59. Racial variation in retinopathy of prematurity
60. Susceptibility to retinopathy of prematurity in Alaskan Natives
61. Norrie's disease: A new hereditary bilateral pseudotumour of the retina
62. Mutations in the Norrie disease gene
63. Missense mutations in the NDP gene in patients with a less severe course of Norrie disease
64. A novel mutation in the Norrie disease gene
65. Familial exudative vitreoretinopathy
66. Autosomal recessive familial exudative vitreoretinopathy: Evidence for genetic heterogeneity
67. X-linked recessive familial exudative vitreoretinopathy
68. A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy
69. Missense mutation (Arg 121Trp) in the Norrie disease gene associated with X-linked exudative vitreoretinopathy
70. Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of familial exudative vitreoretinopathy
71. Norrie disease and exudative vitreoretinopathy in families with affected female carriers
72. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity
73. Insertion and deletion mutations in the dinucleotide repeat region of the Norrie disease gene in patients with advanced retinopathy of prematurity
74. Identification of a new Norrie disease gene mutation in an African-American infant with advanced retinopathy of prematurity
75. The effect of anemia on retinopathy of prematurity in extremely low birth weight infants
76. Threshold retinopathy of prematurity in Lithuania: Tendencies during three years. Progress in retinopathy of prematurity
77. Risk factors associated with retinopathy of prematurity (ROP) in northern Jutland, Denmark 1990-1993
78. Norrie disease in a family with a manifesting female carrier
79. Peripheral retinopathy in offspring of carriers of Norrie disease gene mutations. Possible transplacentel effect of abnormal Norrin
80. Missense mutations in Norrie disease gene are not associated with advanced stages of retinopathy of prematurity in Kuwaiti Arabs
81. Retinopathy of prematurity: Mutations in the Norrie disease gene and the risk of progression to advanced stages
82. Familial exudative vitreoretinopathy linked to D11S533 in a large Asian family with consanguinity
83. A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13
84. Assisted conception and retinopathy of prematurity
85. Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: A retrospective cohort study
86. In vitro fertilisation and stage 3 retinopathy of prematurity
87. Ocular abnormalities associated with cerebral palsy after preterm birth
88. Poor postnatal weight gain: A risk factor for severe retinopathy of prematurity
89. Retinopathy of prematurity: Incidence and risk factors
90. Retinopathy of prematurity
91. Does candidemia predict threshold retinopathy of prematurity in extremely low birth weight (
92. Retinopathy of prematurity at an urban center: Association with Candida sepsis. Progress in retinopathy of prematurity
93. Lack of efficacy of light reduction in preventing retinopathy of prematurity
94. Effect of chronic intrauterine stress on the disappearance of tunica vasculosa lentis of the fetal eye: A neonatal observation
95. Retinopathy of prematurity in Sri Lanka
96. Evidence for changing guidelines for routine screening for retinopathy of prematurity
97. Avoidance and treatment of retinopathy of prematurity